PCF Group S.A. approved a capital increase on 10 February 2023 through the issuance of new Series E ordinary bearer shares.

According to "Current Report No. 6/2023: Issuance of Shares as Part of Target Capital Increase": PCF Group S.A. approved a capital increase on 10 February 2023 through the issuance of new Series E ordinary bearer shares.

The capital injection is strategically intended to increase PCF Group’s equity stake in its Katowice-based subsidiary, Incuvo S.A.

According to "Current Report No. 6/2023: Issuance of Shares as Part of Target Capital Increase": The capital injection is strategically intended to increase PCF Group’s equity stake in its Katowice-based subsidiary, Incuvo S.A.

Existing shareholders have been denied pre-emptive rights to purchase the newly issued Series E shares.

According to "Current Report No. 6/2023: Issuance of Shares as Part of Target Capital Increase": Existing shareholders have been denied pre-emptive rights to purchase the newly issued Series E shares.

The board is pursuing the formal dematerialisation of the new shares and their subsequent listing on the Warsaw Stock Exchange.

According to "Current Report No. 6/2023: Issuance of Shares as Part of Target Capital Increase": The board is pursuing the formal dematerialisation of the new shares and their subsequent listing on the Warsaw Stock Exchange.

The issuance requires a statutory amendment to the company’s articles to formally incorporate the new Series E share class.

According to "Current Report No. 6/2023: Issuance of Shares as Part of Target Capital Increase": The issuance requires a statutory amendment to the company’s articles to formally incorporate the new Series E share class.

This corporate action follows the company's previously disclosed intent to strengthen its financial position and investment in Incuvo S.A. as outlined in report No. 2/2023.

According to "Current Report No. 6/2023: Issuance of Shares as Part of Target Capital Increase": This corporate action follows the company's previously disclosed intent to strengthen its financial position and investment in Incuvo S.A. as outlined in report No. 2/2023.

Back to report

Key Insights

Current Report No. 6/2023: Issuance of Shares as Part of Target Capital Increase

PCF Group~1 min full read

01
PCF Group S.A. approved a capital increase on 10 February 2023 through the issuance of new Series E ordinary bearer shares.
02
The capital injection is strategically intended to increase PCF Group’s equity stake in its Katowice-based subsidiary, Incuvo S.A.
03
Existing shareholders have been denied pre-emptive rights to purchase the newly issued Series E shares.
04
The board is pursuing the formal dematerialisation of the new shares and their subsequent listing on the Warsaw Stock Exchange.
05
The issuance requires a statutory amendment to the company’s articles to formally incorporate the new Series E share class.
06
This corporate action follows the company's previously disclosed intent to strengthen its financial position and investment in Incuvo S.A. as outlined in report No. 2/2023.

That's the gist.

Dive into the full report for the data, charts, and sources behind these takeaways.

Read the full report